KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Short-term Investments (2016 - 2025)

Evolent Health has reported Short-term Investments over the past 11 years, most recently at $26.1 million for Q4 2025.

  • Quarterly results put Short-term Investments at $26.1 million for Q4 2025, down 55.93% from a year ago — trailing twelve months through Dec 2025 was $26.1 million (down 55.93% YoY), and the annual figure for FY2025 was $26.1 million, down 55.93%.
  • Short-term Investments for Q4 2025 was $26.1 million at Evolent Health, up from $23.7 million in the prior quarter.
  • Over the last five years, Short-term Investments for EVH hit a ceiling of $75.7 million in Q4 2021 and a floor of $13.8 million in Q4 2023.
  • Median Short-term Investments over the past 5 years was $24.0 million (2025), compared with a mean of $33.1 million.
  • Biggest five-year swings in Short-term Investments: surged 426.54% in 2021 and later crashed 80.85% in 2022.
  • Evolent Health's Short-term Investments stood at $75.7 million in 2021, then crashed by 80.85% to $14.5 million in 2022, then dropped by 5.0% to $13.8 million in 2023, then surged by 330.67% to $59.3 million in 2024, then tumbled by 55.93% to $26.1 million in 2025.
  • The last three reported values for Short-term Investments were $26.1 million (Q4 2025), $23.7 million (Q3 2025), and $24.4 million (Q2 2025) per Business Quant data.